Biosafety

IBC mastery means fastest turnaround time to approval

The traditional IBC process can yield unpredictable and uneven results. That’s why so many sponsors and CROs turn to WCG. They know we offer a 15-year track record of success fueled by our superior Biosafety solution. We base that solution on central management of IBCs and the world’s largest network of standing committees and expert committee members.

Today, sponsors and CROs that use WCG Biosafety achieve consistently faster approval turnaround times. That’s due to our rapid IBC organization and central management of local committees that combine to streamline workflow.

We also save institutions and Academic Medical Centers (AMCs) the burden of managing and administering IBCs, so they can focus on preparing the clinical study for launch.

Trust WCG Biosafety to implement any IBC review

We have managed and administered more than 700 local IBCs and studies from single investigator clinics to large AMCs.

We offer a fully managed IBC solution that provides centrally administered Institutional Biosafety Committees (IBCs) for oversight of human gene therapy and human gene transfer.

WCG Biosafety offers solutions to biotech startups, vaccine manufacturers, academic institutions, medical centers, pharmaceutical companies CROs and government agencies. We operate IBCs in the United States, Canada, Africa, South America, Central America, the Caribbean, and Europe.

No matter what your IBC need, WCG Biosafety can ensure safe, streamlined implementation to approval.

Why WCG Biosafety is your safest, smartest—easiest—IBC decision

WCG is by far the most experienced and knowledgeable provider of Biosafety solutions. Our team has evaluated more than 250 human gene transfer protocols — more than any organization outside the FDA and NIH.  In addition, we an unsurpassed record of more than 700 IBC committees.

Perhaps most importantly, an incomparable team of high-level experts in human gene therapy research supports WCG Biosafety’s IBC process. Our team understands your study intimately from the outset, so you are assured of the integrity of the review process.

Finally, WCG Biosafety created the world’s largest, most extensive, integrated IRB-IBC network, based on some 2500 IRB active sites and 270 active IBC sites globally. Clients that also utilize WCG IRB services reap even greater synergies, because smoother communications between IRBs and IBCs accelerate both review processes.

Ethical & Regulatory Review Resources


Schedule a consultation with the Biosafety experts at WCG

Use this form to request a meeting with the WCG team. One of our team members will respond to your inquiry as quickly as possible.